3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase NA
1
Phase EARLY_PHASE1
1
Phase 2
1
Phase 1
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
1
CNS
1
Conditions
Lung Neoplasms
1
Glioblastoma
1
Edema
1
Atrial Fibrillation
1
Interventions
Cyclophosphamide
299
Cisplatin
298
Paclitaxel
257
Radiotherapy
255
Fluorouracil
234
Carboplatin
234
Docetaxel
230
Doxorubicin
216
Dexamethasone
166
Gemcitabine
156
Vincristine
147
Etoposide
136
Leucovorin
133
Capecitabine
129
Bevacizumab
129
Prednisone
125
Rituximab
118
Methotrexate
118
Cytarabine
110
Filgrastim
99
Trastuzumab
97
Oxaliplatin
96
pembrolizumab
83
Pemetrexed
73
Epirubicin
70
Tamoxifen
69
Drug Therapy
69
Irinotecan
65
Granulocyte Colony-Stimulating Factor
60
Daunorubicin
58
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Completed
×
Losartan
×
Clear all
NCT01805453
2020-05-08
ASTER
Assistance Publique - Hôpitaux de Paris
Phase 3
Completed
80 enrolled
NCT01281787
2014-06-18
PRESAGE
European Institute of Oncology
Phase 3
Completed
320 enrolled